Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells. - Wikidata - awgldk - TriplyDB

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

http://www.wikidata.org/entity/Q41876229

about

Trial Watch: Proteasomal inhibitors for anticancer therapy Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.Avidity characterization of genetically engineered T-cells with novel and established approaches.Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions.TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.

P2860

Q28082910-7A6646C3-530A-4107-9893-DA016CC5C1DA Q34070374-7218D808-9477-47E1-A4A3-2486CBFFF9B3 Q36076472-FBE87271-1E2A-4992-B1E0-F86BD0F6FC61 Q36425747-79D8DF0F-91A0-4448-AFA0-4963C48CD31C Q37499526-002133E7-0FCE-443A-99E3-841F8F0A6669 Q37580419-26160820-C105-4C65-AFAF-822BA24C76B1 Q38335303-008B7BB2-3D4C-4B5B-9508-AE0AAA830886 Q38920996-290F9315-CE20-4C68-84DC-FBDC5756B3C1 Q39023473-09895FC4-29D5-4DC1-90AC-7DCC02EFFEE2 Q45941281-FE9880AC-EB72-4676-9A52-F1754D064454

P2860

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

http://www.wikidata.org/entity/Q41876229

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

@en

type

label

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

@en

prefLabel

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

@en

P1433

Q41876229-7D82C0FF-EB2B-4618-A304-865F050FA4DA

P1476

Q41876229-C725B47A-00AB-4C2D-9D19-929A0CB11DEE

P2093

Q41876229-208276D6-B849-4FDB-9DCD-691B5C81D282

Q41876229-3F838E09-634A-48C7-ABC8-CB07A69B38C4

Q41876229-6539983D-A488-4BE5-B27E-185C8CAC1413

Q41876229-68BE36B2-020C-4D14-AC5A-176C2BEAAE75

Q41876229-92A48C7D-3F62-4C9D-9593-896369B09CC8

Q41876229-A2FB0F19-83C3-4B56-B6AE-8EA572F2C68D

P2860

Q41876229-0041286B-E0E3-4456-8BF8-7CC141DC00F8

Q41876229-0E138177-D9A7-4021-A567-BB0EF4784B54

Q41876229-19721DF1-78D8-45FD-A43D-24D9243C620D

Q41876229-604C9015-E908-4A8F-85E5-6D17C6C7CDFD

Q41876229-7A132849-3960-4411-87D6-D7E1AFD676FC

Q41876229-874AE2FE-1762-4925-A173-850A055CA2E9

Q41876229-AD7167C0-65E0-43E7-8CA6-68D5F68F526E

Q41876229-BC6F58AA-61AD-4388-8066-30F2774E78D1

Q41876229-BDCB88CE-93E0-4EB7-A7C3-E04D6E67D2DF

Q41876229-D6647A6C-CF83-497C-B799-CD319B71DE2B

P304

Q41876229-EACF86E7-C355-4FC9-BC74-C9F13DFA8D7F

P31

Q41876229-67747A24-E453-43B6-8799-9ECDE3754A82

P356

Q41876229-6F61FC7F-C97C-470E-A75B-ADED54F7A12D

P433

Q41876229-33F2E431-E580-4F73-A284-47AB8250323D

P478

Q41876229-ABB02BA5-13C8-4F27-A296-948AB7E9ACF3

P577

Q41876229-2FD3D8FA-A560-452A-B596-61951C36F602

P5875

Q41876229-B936060E-E9AF-46D3-B1A4-619F454F965F

P698

Q41876229-D600FB3B-9F7E-4B22-A028-18AAC672134C

P932

Q41876229-3A51EF0A-89FD-4097-9FB9-5C9B92D3C03F

P356

P1433

P1476

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

@en

P2093

Andrew B Gerry

http://www.w3.org/2001/XMLSchema#string

Bent K Jakobsen

http://www.w3.org/2001/XMLSchema#string

Deborah H Sutton

http://www.w3.org/2001/XMLSchema#string

Giovanna Bossi

http://www.w3.org/2001/XMLSchema#string

Namir J Hassan

http://www.w3.org/2001/XMLSchema#string

Samantha J Paston

http://www.w3.org/2001/XMLSchema#string

P2860

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

A third-generation lentivirus vector with a conditional packaging system

Monoclonal TCR-redirected tumor cell killing.

Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo.

Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.

The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor.

Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.

Defective presentation of endogenous antigen by a cell line expressing class I molecules.

ImmTACs: Novel bi-specific agents for targeted cancer therapy.

Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies.

P304

e26840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.26840

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259990037

http://www.w3.org/2001/XMLSchema#string

P698

24482751

http://www.w3.org/2001/XMLSchema#string

P932

3894244

http://www.w3.org/2001/XMLSchema#string